|Bid||53.52 x 800|
|Ask||53.57 x 900|
|Day's Range||51.38 - 53.74|
|52 Week Range||42.90 - 155.86|
|Beta (5Y Monthly)||0.76|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 01, 2022 - Nov 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||131.08|
SAN DIEGO, October 04, 2022--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2022 results after the financial markets close on Wednesday, November 2, 2022. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its third quarter 2022 financial and operating results.
In this article, we discuss the 10 best diabetes stocks to buy now. If you want to read about some more diabetes stocks, go directly to 5 Best Diabetes Stocks To Buy Now. The diabetes market has grown in the past few years as organizations and individuals in the private and public domains make significant […]
InnovAge Holding, Spirit AeroSystems Holdings, Tandem Diabetes Care and HCI Group have been highlighted in this Screen of The Week article.